Refractory epilepsy associated with microglial activation

Neurologist

Volumn 17, Issue 5, 2011, Pages 249-254

  Najjar, Souhel ^a,b   Pearlman, Daniel ^a,c   Miller, Douglas C ^a,d   Devinsky, Orrin ^a,b  

^a Department of Neurology Neuropathology Neurosurgery and Psychiatry   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d University of Missouri   (United States)

Author keywords

cytokines; epilepsy; microglial activation and proliferation (MAP); neuroinflammation; seizures

Indexed keywords

ANTICONVULSIVE AGENT; IMMUNOGLOBULIN;

BRAIN ATROPHY; CELL ACTIVATION; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; EPILEPSY; FRONTOTEMPORAL ATROPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOTHERAPY; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEMORY DISORDER; MICROGLIAL ACTIVATION AND PROLIFERATION; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PRIORITY JOURNAL; REFRACTORY EPILEPSY; REVIEW; SEIZURE; TREATMENT FAILURE; TREATMENT RESPONSE; VERBAL MEMORY; VISUAL MEMORY;

CELL PROLIFERATION; DNA; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; FRONTAL LOBE; HUMANS; IMMUNOTHERAPY; INFLAMMATION; IODIDE PEROXIDASE; MALE; MICROGLIA; NERVE TISSUE PROTEINS; NEURONS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 80052642998     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e31822aad04     Document Type: Review

References (58)

1. Streit WJ, Kincaid-Colton CA. The brain's immune system. Sci Am. 1995;273:58-61.
2. Heneka Mt, O'Banion MK. Inflammatory processes in Alzheimer's disease. J Neuroimmunol. 2007;184:69-91. (Pubitemid 46365992)
3. Mount MP, Lira A, Grimes D, et al. J Neurosci. 2007;27: 3328-3337.
4. Borchelt DR. Amyotrophic lateral sclerosis-are microglia killing motor neurons? N Engl J Med. 2006;355:1611-1613. (Pubitemid 44547815)
5. Sapp E, Kegel KB, Aronin N, et al. Early and progressive accumulation of reactive microglia in the Huntington disease brain. J Neuropathol Exp Neurol. 2001;60:161-172. (Pubitemid 32172419)
6. Stadelmann C, Wegner C, Brück W. Inflammation, demyelination, and degeneration-Recent insights from MS pathology. Biochim Biophys Acta. 2010.
7. Vargas DL, Nascimbene C, Krishnan C, et al. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005;57:67-81. (Pubitemid 40053317)
8. Wiart M, Davoust N, Pialat JB, et al. MRI monitoring of neuroinflammation in mouse focal ischemia. Stroke. 2007;38:131-137. (Pubitemid 46035618)
9. Turrin NP, Rivest. S. Innate immune reaction in response to seizures: implications for the neuropathology associated with epilepsy. Neurobiol Dis. 2004;16:321-334. (Pubitemid 38757314)
10. Vezzani A. Inflammation and epilepsy. Epilepsy Curr. 2005;5: 1-6.
11. Thom M. Recent advances in the neuropathology of focal lesions in epilepsy. Expert Rev Neurother. 2004;4:973-984. (Pubitemid 39482270)
12. Van Rossum D, Hanisch UK. Microglia. Metab Brain Dis. 2004;19:393-411. (Pubitemid 39361196)
13. Streit WJ, Walter SA, Pennell NA. Reactive microgliosis. Prog Neurobiol. 1999;57:563-581. (Pubitemid 29148415)
14. Pashenkov M, Teleshova N, Link H. Inflammation in the central nervous system: the role for dendritic cells. Brain Pathology. 2003;13:23-33. (Pubitemid 36133789)
15. Siglienti I, Chan A, Kleinschnitz C, et al. Downregulation of transforming growth factor-beta2 facilitates inflammation in central nervous systems by reciprocal astrocyte/microglia interactions. J Neuropathol Exp Neurol. 2007;66:47-56. (Pubitemid 46066788)
16. Ravizza T, Rizzi M, Perego C, et al. Inflammatory response and glia activation in developing rat hippocampus after status epilepticus. Epilepsia. 2005;46:113-117. (Pubitemid 40962132)
17. Vezzani A, Conti M, De Luigi A, et al. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainite application: functional evidence for enhancement of electrographic seizures. J Neurosci. 1999;19: 5054-5065. (Pubitemid 29270140)
18. De Simoni MG, Perego C, Ravizza T, et al. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci. 2000;12:2623-2633. (Pubitemid 30497055)
19. Eriksson C, Tehranian R, Iverfeldt K, et al. Increased expression of mRNA encoding interleukin-1beta and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration. J Neurosci Res. 2000;60:266-279. (Pubitemid 30198634)
20. Rizzi M, Perego C, Aliprandi M, et al. Glia activation and cytokine increase in rat hippocampus by kainic acid-induced status epilepticus during postnatal development. Neurobiol Dis. 2003;14: 494-503. (Pubitemid 37543527)
21. Pocock JM, Liddle AC. Microglial signaling cascades in neurodegenerative disease. Prog Brain Res. 2001;132:555-565.
22. Vezzani A, Ravizza T, Balosso S, et al. Glia as a source of cytokines: implications for neuronal excitability and survival. Epilepsia. 2008;49:24-32. (Pubitemid 351143763)
23. Riazi K, Galic MA, Pittman QJ. Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res. 2010;89:34-42.
24. Savin C, Triesch J, Meyer-Hermann M. Epileptogenesis due to glia-mediated synaptic scaling. J R Soc Interface. 2009;6: 655-668.
25. Kanemoto K, Kawasaki J, Yuasa S, et al. Increased frequency of interleukin-1beta-511T allele in patients with temporal lobe epilepsy, hippocampal sclerosis, and prolonged febrile convulsion. Epilepsia. 2003;44:796-799. (Pubitemid 36754004)
26. Jankowsky JL, Patterson PH. The role of cytokines and growth factors in seizures and their sequelae. Prog Neurobiol. 2001;63: 125-149.
27. Vezzani A, Moneta D, Richichi C, et al. Functional role of inflammatory cytokines and anti-inflammatory molecules in seizures and epileptogenesis. Epilepsia. 2002;43:30-35. (Pubitemid 34864203)
28. Aarli JA. Role of cytokines in neurological disorders. Curr Med Chem. 2003;10:1931-1937. (Pubitemid 37139055)
29. Dube C, Vezzani A, Behrens M, et al. Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann Neurol. 2005;57:152-155. (Pubitemid 40053330)
30. Suzumura A, Takeuchi H, Zhang G, et al. Roles of glia-derived cytokines on neuronal degeneration and regeneration. Ann N Y Acad Sci. 2006;1088:219-229. (Pubitemid 47092033)
31. Jara JH, Singh BB, Floden AM, et al. Tumor necrosis factor alpha stimulates NMDA receptor activity in mouse cortical neurons resulting in ERK-dependent death. J Neurochem. 2007;100: 1407-1420.
32. Aronica E, van Vliet EA, Mayboroda OA, et al. Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy. Eur J Neurosci. 2000;12:2333-2344. (Pubitemid 30497031)
33. Rimaniol AC, Haik S, Martin M, et al. Na+-dependent highaffinity glutamate transport in macrophages. J Immunol. 2000;164: 5430-5438. (Pubitemid 30305226)
34. Bano D, Nicotera P. Ca2+ signals and neuronal death in brain ischemia. Stroke. 2007;38:674-676. (Pubitemid 46184239)
35. Mander P, Brown GC. Activation of microglial NADPH oxidase is synergistic with glial iNOS expression in inducing neuronal death. J Neuroinflammation. 2005;2:20.
36. Brown GC, Bal-Price A. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol. 2003;27:325-355. (Pubitemid 38156291)
37. Gibbons HM, Dragunow M. Microglia induce neural cell death via a proximity-dependent mechanism involving nitric oxide. Brain Res. 2006;1084:1-15.
38. Kang JQ, Shen W, Macdonald RL. Why does fever trigger febrile seizures? GABAA receptor gamma2 subunit mutations associated with idiopathic generalized epilepsies have temperature-dependant trafficking deficiencies. J Neurosci. 2006;26:2590-2597. (Pubitemid 44699020)
39. Chengyun D, Guoming L, Elia M, et al. Expression of multidrug resistance type 1 gene (MDR1) P-glycoprotein in intractable epilepsy with different aetiologies: a double-labelling and electron microscopy study. Neurol Sci. 2006;27:245-251. (Pubitemid 44463785)
40. Aronica E, Gorter JA, Jansen GH, et al. Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors. Neuroscience. 2003;118:417-429. (Pubitemid 36423257)
41. Volk HA, Löscher W. Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures. Brain. 2005.
42. Van Vliet EA, Redeker S, Aronica E, et al. Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats. Epilepsia. 2005;46:1569-1580. (Pubitemid 44921930)
43. Somera-Molina KC, Robin B, Somera CA, et al. Glial activation links early-life seizures and long-term neurological dysfunction: evidence using a small molecule inhibitor of proinflammatory cytokine upregulation. Epilepsia. 2007;48:1785-1800. (Pubitemid 47352870)
44. Zhang G, Raol YS, Hsu FC, et al. Long-term alterations in glutamate receptor transporter expression following early-life seizures are associated with increased seizure susceptibility. J Neurochem. 2004;88:91-101. (Pubitemid 38030212)
45. Ivens S, Kaufer D, Flores LP, et al. TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain. 2007;130:535-547. (Pubitemid 46181106)
46. Fabene PF, Navarro Mora G, Martinello M, et al. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med. 2008;14:1377-1383.
47. Johnson EA, Kan RK. The acute phase response and soman-induced status epilepticus: temporal, regional and cellular changes in rat brain cytokine concentrations. J Neuroinflammation. 2010;7:40.
48. Foresti ML, Arisi GM, Katki K, et al. Chemokine CCL2 and its receptor CCR2 are increased in the hippocampus following pilocarpine-induced status epilepticus. J Neuroinflammation. 2009;6:40.
49. Angoa-Pérez M, Kreipke CW, Thomas DM, et al. Boman increases neuronal COX-2 levels: possible link between seizures and protracted neuronal damage. Neurotoxicology. 2010.
50. Jansson L, Wennström M, Johanson A, et al. Glial cell activation in response to electroconvulsive seizures. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:1119-1128.
51. Choi J, Nordli DR Jr, Alden TD, et al. Cellular injury and neuroinflammation in children with chronic intractable epilepsy. J Neuroinflammation. 2009;6:38.
52. Beach TG, Woodhurst WB, MacDonald DB, et al. Reactive microglia in hippocampal sclerosis associated with human temporal lobe epilepsy. Neurosci Lett. 1995;191:27-30.
53. Boer K, Spliet WG, van Rijen PC, et al. Evidence of activated microglia in focal cortical dysplasia. J Neuroimmunol. 2006;173:188-195.
54. Boer K, Jansen F, Nellist M, et al. Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy Res. 2008;78:7-21. (Pubitemid 350296774)
55. Chauveau F, Van Camp N, Dollé F, et al. Comparitive evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation. J Nucl Med. 2009;50:468-476.
56. Cagnin A, Gerhard A, Banati RB. The concept of in vivo imaging of neuroinflammation with [11C](R)-PIK11195 PET. Ernst Schering Res Found Worshop. 2002;39:179-191.
57. Banati RB. Visualising microglial activation in vivo. Glia. 2002;40:206-217. (Pubitemid 35337378)
58. Papadopoulos V, Baraldi M, Guilarte TR, et al. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci. 2006;27:402.